Stroke Reperfusion Therapy Following Dabigatran Reversal With Idarucizumab in a National Cohort
- PMID: 33903215
- DOI: 10.1212/WNL.0000000000009542
Stroke Reperfusion Therapy Following Dabigatran Reversal With Idarucizumab in a National Cohort
Erratum for
-
Stroke reperfusion therapy following dabigatran reversal with idarucizumab in a national cohort.Neurology. 2020 May 12;94(19):e1968-e1972. doi: 10.1212/WNL.0000000000009155. Epub 2020 Feb 20. Neurology. 2020. PMID: 32079737
Publication types
LinkOut - more resources
Full Text Sources